Laura A Linynsky Net Worth

The estimated Net Worth of Laura A Linynsky is at least $405 Mille dollars as of 27 August 2024. Laura Linynsky owns over 7,000 units of Pediatrix Medical Inc stock worth over $326,841 and over the last 2 years Laura sold MD stock worth over $78,120.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Laura Linynsky MD stock SEC Form 4 insiders trading

Laura has made over 1 trades of the Pediatrix Medical Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Laura sold 7,000 units of MD stock worth $78,120 on 27 August 2024.

The largest trade Laura's ever made was selling 7,000 units of Pediatrix Medical Inc stock on 27 August 2024 worth over $78,120. On average, Laura trades about 1,750 units every 0 days since 2022. As of 27 August 2024 Laura still owns at least 30,805 units of Pediatrix Medical Inc stock.

You can see the complete history of Laura Linynsky stock trades at the bottom of the page.

What's Laura Linynsky's mailing address?

Laura's mailing address filed with the SEC is 1301, Concord Terrace, Sunrise, Broward County, Florida, 33323, United States.

Insiders trading at Pediatrix Medical Inc

Over the last 16 years, insiders at Pediatrix Medical Inc have traded over $151,130,633 worth of Pediatrix Medical Inc stock and bought 737,264 units worth $19,901,767 . The most active insiders traders include Roger Md Medel, Manuel Kadre e Michael Fernandez. On average, Pediatrix Medical Inc executives and independent directors trade stock every 25 days with the average trade being worth of $297,048. The most recent stock trade was executed by James D Swift on 30 August 2024, trading 11,100 units of MD stock currently worth $119,769.

What does Pediatrix Medical Inc do?

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in

Complete history of Laura Linynsky stock trades at Pediatrix Medical Inc

Pediatrix Medical Inc executives and stock owners

Pediatrix Medical Inc executives and other stock owners filed with the SEC include:

• Roger Medel,
  Director
• John Pepia,
  Senior Vice President, Chief Accounting Officer
• Dominic Andreano,
  Executive Vice President, General Counsel, Secretary
• Dr. Roger J. Medel,
  Co-Founder & Director
• Mark S. Ordan,
  CEO & Director
• Dr. Roger Mack Hinson M.D.,
  Pres of Pediatrix & Obstetrix Medical Groups
• Dominic J. Andreano,
  Exec. VP, Gen. Counsel & Sec.
• John C. Pepia,
  Sr. VP & Chief Accounting Officer
• C. Marc Richards,
  Exec. VP, CFO & Principal Accounting Officer
• Michael Rucker,
  Independent Director
• Manuel Kadre,
  Lead Independent Director
• Paul Gabos,
  Independent Director
• Waldemar Carlo,
  Independent Director
• Karey Barker,
  Independent Director
• Charles Lynch,
  Vice President, Strategy and Investor Relations
• Shirley Weis,
  Independent Director
• John Starcher,
  Independent Director
• Thomas McEachin,
  Independent Director
• Nikos Nikolopoulos,
  Executive Vice President, Chief Strategy and Growth Officer
• C. Marc Richards,
  Chief Financial Officer, Executive Vice President
• Mark Ordan,
  Chief Executive Officer
• Guy Sansone,
  Independent Chairman of the Board
• Claire M. Fair,
  Sr. VP & Chief HR Officer
• Dr. James D. Swift M.D.,
  Chief Devel. Officer
• Dana Dreher-Rodwell,
  VP & Chief Compliance Officer
• Charles W. Lynch C.F.A.,
  Sr. VP of Fin., Strategy & Investor Relations
• Sylvia Jean Young,
  
• Donna E Shalala,
  Director
• Cesar L Alvarez,
  Director
• Michael D Stanley,
  President, Pediatrix Division
• Karl B Wagner,
  Chief Financial Officer
• Md Pascal J Goldschmidt,,
  Director
• Enrique Sosa,
  Director
• Vivian Lopez Blanco,
  Chief Financial Officer
• Michael Fernandez,
  Director
• Nicholas J Nikolopoulos,
  EVP Chf Strategy & Growth Offi
• David A. Clark,
  Chief Operating Officer
• Joseph M Calabro,
  President and COO
• Laura A Linynsky,
  
• Roger K Freeman,
  Director
• William C Hawk,
  COO American Anesthesiology
• Thomas W Hawkins,
  SVP, General Counsel and Secy.
• Frederick V Miller,
  President, Pediatrix Division
• Dany Garcia,
  Director
• Carlos A Migoya,
  Director
• Stephen D Farber,
  Former Chief Financial Officer
• Roger Mack Hinson,
  Pres., PDX & OBX Medical Group
• Mary Ann E Moore,
  EVP, General Counsel & Sec
• Curtis Pickert,
  EVP, Chief Operating Officer
• James D Swift,
  Chief Executive Officer
• Lee Wood,
  EVP, Natl & Market Operations